Nisa Investment Advisors
RCUS icon

Nisa Investment Advisors’s Arcus Biosciences RCUS Stock Holding History

Nisa Investment Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Buy
3,326
+903
+37% +$22.3K ﹤0.01% 1540
2026
Q1 		$52.3K Buy
2,423
+1,251
+107% +$27K ﹤0.01% 1652
2025
Q4 		$27.9K Buy
1,172
+72
+7% +$1.47K ﹤0.01% 1817
2025
Q3 		$15K Buy
1,100
+62
+6% +$645 ﹤0.01% 2117
2025
Q2 		$8.45K Buy
1,038
+302
+41% +$2.58K ﹤0.01% 2329
2025
Q1 		$5.78K Buy
736
+45
+7% +$522 ﹤0.01% 2218
2024
Q4 		$10.3K Hold
691
– – ﹤0.01% 2127
2024
Q3 		$10.6K Sell
691
-103
-13% -$1.62K ﹤0.01% 2087
2024
Q2 		$12.1K Buy
794
+55
+7% +$888 ﹤0.01% 2091
2024
Q1 		$14K Buy
739
+92
+14% +$1.59K ﹤0.01% 1977
2023
Q4 		$12.4K Sell
647
-40
-6% -$639 ﹤0.01% 1994
2023
Q3 		$12.3K Buy
687
+10
+1% +$201 ﹤0.01% 2133
2023
Q2 		$13.8K Buy
677
+335
+98% +$6.38K ﹤0.01% 2195
2023
Q1 		$6K Sell
342
-1,537
-82% -$29.4K ﹤0.01% 2226
2022
Q4 		$39K Sell
1,879
-25
-1% -$688 ﹤0.01% 1852
2022
Q3 		$49K Buy
1,904
+37
+2% +$978 ﹤0.01% 1749
2022
Q2 		$47K Sell
1,867
-53
-3% -$1.3K ﹤0.01% 1750
2022
Q1 		$61K Sell
1,920
-180
-9% -$6.03K ﹤0.01% 1780
2021
Q4 		$65K Sell
2,100
-350
-14% -$13.6K ﹤0.01% 1649
2021
Q3 		$85K Hold
2,450
– – ﹤0.01% 1774
2021
Q2 		$67K Hold
2,450
– – ﹤0.01% 1859
2021
Q1 		$69K Hold
2,450
– – ﹤0.01% 1904
2020
Q4 		$64K Buy
+2,450
New +$59.3K ﹤0.01% 1915

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Nisa Investment Advisors's RCUS Position: Q2 2026 in Review

Nisa Investment Advisors increased its Arcus Biosciences (RCUS) stake by 37% in Q2 2026, buying an estimated $22.3K and bringing the position to 3,326 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

Nisa Investment Advisors first reported a position in RCUS in Q4 2020 and has held it in 23 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Nisa Investment Advisors held 3,326 shares of Arcus Biosciences worth $103K as of Q2 2026.
  • Nisa Investment Advisors bought 903 Arcus Biosciences shares in Q2 2026, an estimated $22.3K.
  • Arcus Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1540 holding.
  • Nisa Investment Advisors first reported a position in Arcus Biosciences in Q4 2020 and has held it in 23 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.